As of 2025-07-18, the Intrinsic Value of Bioporto A/S (BIOPOR.CO) is (15.02) DKK. This BIOPOR.CO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1.37 DKK, the upside of Bioporto A/S is -1,196.10%.
The range of the Intrinsic Value is (83.37) - (8.44) DKK
Based on its market price of 1.37 DKK and our intrinsic valuation, Bioporto A/S (BIOPOR.CO) is overvalued by 1,196.10%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (83.37) - (8.44) | (15.02) | -1196.1% |
| DCF (Growth 10y) | (13.40) - (129.20) | (23.61) | -1823.6% |
| DCF (EBITDA 5y) | (3.67) - (4.62) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | (6.84) - (8.95) | (1,234.50) | -123450.0% |
| Fair Value | -0.90 - -0.90 | -0.90 | -165.94% |
| P/E | (1.70) - (1.84) | (1.92) | -239.8% |
| EV/EBITDA | (1.95) - (1.62) | (1.73) | -226.6% |
| EPV | (1.70) - (2.39) | (2.05) | -249.3% |
| DDM - Stable | (2.75) - (38.36) | (20.56) | -1600.4% |
| DDM - Multi | (6.44) - (70.58) | (11.85) | -964.8% |
| Market Cap (mil) | 622.90 |
| Beta | 0.39 |
| Outstanding shares (mil) | 454.67 |
| Enterprise Value (mil) | 600.29 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.51% |
| Cost of Debt | 7.35% |
| WACC | 6.52% |